• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西麻风病人统一多药疗法临床试验(U-MDT/CT-BR)结果:细菌学指数下降。

Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.

作者信息

Penna Maria Lucia Fernandes, Bűhrer-Sékula Samira, Pontes Maria Araci de Andrade, Cruz Rossilene, Gonçalves Heitor de SáOliveira, Penna Gerson Oliveira

出版信息

Lepr Rev. 2014 Dec;85(4):262-6.

PMID:25675650
Abstract

BACKGROUND

Many believe that the regular treatment for multibacillary (MB) leprosy cases could be shortened. A shorter treatment allowing uniformity in treatment for all cases renders case classification superfluous and therefore simplifies leprosy control.

OBJECTIVE

To evaluate the association between treatment duration and the trend in bacteriological index (BI) decrease over time among patients given Uniform MDT (UMDT) compared to those given regular MDT (RMDT).

METHODS

An open-label randomised clinical trial to compare the present routine treatment with one lasting six month. Patient intake was from March 2007 to February 2012. To evaluate the trend of BI as a function of time, a multilevel linear with mixed effects model was fixed to the two study groups and also four groups after stratification by BI, less than 3 and 3 or more.

RESULTS

The BI fall was higher among those taking RMDT, this difference however was not statistically significant.

CONCLUSION

The results presented here support the possibility of use of UMDT in the field, but further follow up is still needed for a final conclusion.

摘要

背景

许多人认为多菌型麻风病例的常规治疗疗程可以缩短。缩短治疗疗程可使所有病例的治疗趋于统一,使病例分类变得多余,从而简化麻风病防治工作。

目的

评估与接受常规联合化疗(RMDT)的患者相比,接受统一多药联合化疗(UMDT)的患者治疗持续时间与细菌学指数(BI)随时间下降趋势之间的关联。

方法

一项开放标签随机临床试验,比较现行常规治疗与为期6个月的治疗。患者纳入时间为2007年3月至2012年2月。为评估BI随时间变化的趋势,对两个研究组以及按BI分层(小于3和3及以上)后的四个组采用了具有混合效应的多水平线性模型。

结果

接受RMDT的患者BI下降幅度更大,但这种差异无统计学意义。

结论

此处呈现的结果支持在现场使用UMDT的可能性,但仍需进一步随访才能得出最终结论。

相似文献

1
Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.巴西麻风病人统一多药疗法临床试验(U-MDT/CT-BR)结果:细菌学指数下降。
Lepr Rev. 2014 Dec;85(4):262-6.
2
Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients.巴西麻风病患者统一多药疗法临床试验(U-MDT/CT-BR)的主要结果:多菌型患者的反应频率
Lepr Rev. 2012 Sep;83(3):308-19.
3
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.巴西麻风病患者统一多药疗法(U-MDT/CT-BR):多菌型患者开放标签、随机对照临床试验结果
PLoS Negl Trop Dis. 2017 Jul 13;11(7):e0005725. doi: 10.1371/journal.pntd.0005725. eCollection 2017 Jul.
4
-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.多菌型麻风病患者在接受常规 12 剂量联合化疗(MDT)或统一 6 剂量 MDT 治疗期间和治疗后,特异性抗体减少。
Front Immunol. 2018 May 14;9:915. doi: 10.3389/fimmu.2018.00915. eCollection 2018.
5
Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.基线 ML Flow 测试结果能否预测麻风反应?巴西一项针对麻风病患者统一多药物治疗临床试验入组患者队列的研究。
Infect Dis Poverty. 2016 Dec 6;5(1):110. doi: 10.1186/s40249-016-0203-0.
6
Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).巴西麻风病患者的迟发性复发:统一多药物治疗(U-MDT/CT-BR)的 10 年试验后。
Braz J Infect Dis. 2024 Mar-Apr;28(2):103745. doi: 10.1016/j.bjid.2024.103745. Epub 2024 Apr 30.
7
Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach.巴西麻风病患者统一多药疗法临床试验(U-MDT/CT-BR):不良反应研究方法
An Bras Dermatol. 2018 Jun;93(3):377-384. doi: 10.1590/abd1806-4841.20186709.
8
Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.12个月的世界卫生组织/多药联合治疗麻风病方案与结核分枝杆菌疫苗联合用于多菌型麻风病:136例患者的随访
Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):174-81.
9
Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR).在一项统一六个月多药疗法(U-MDT/CT-BR)临床试验中巴西麻风病患者的患者概况及治疗满意度
Lepr Rev. 2014 Dec;85(4):267-74.
10
The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.皮质类固醇使用对麻风病细菌杀灭、清除及神经损伤的影响;第3部分——对两组各100例多菌型(MB)患者的研究,一组接受多药联合化疗(MDT)+类固醇治疗,另一组仅接受MDT治疗,在完成12个月MDT停药6个月后进行评估。
Lepr Rev. 2010 Mar;81(1):41-58.

引用本文的文献

1
Treatment and Evaluation Advances in Leprosy Neuropathy.麻风神经病变的治疗和评估进展。
Neurotherapeutics. 2021 Oct;18(4):2337-2350. doi: 10.1007/s13311-021-01153-z. Epub 2021 Nov 19.
2
Reply of the authors of the Continuing Medical Education article to Dr. Jaison Barreto and Dr. Laila Laguiche.继续医学教育文章作者对贾森·巴雷托博士和莱拉·拉吉什博士的回复。
An Bras Dermatol. 2018 Jul-Aug;93(4):625-626. doi: 10.1590/abd1806-4841.201893404.
3
-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.
多菌型麻风病患者在接受常规 12 剂量联合化疗(MDT)或统一 6 剂量 MDT 治疗期间和治疗后,特异性抗体减少。
Front Immunol. 2018 May 14;9:915. doi: 10.3389/fimmu.2018.00915. eCollection 2018.
4
Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.麻风病:现状、临床及实验室方面、治疗史以及对所有患者采用统一多药疗法的前景。
An Bras Dermatol. 2017 Nov-Dec;92(6):761-773. doi: 10.1590/abd1806-4841.20176724.
5
New perspectives for the treatment of Hansen's disease.麻风病治疗的新视角。
An Bras Dermatol. 2017 Nov-Dec;92(6):760. doi: 10.1590/abd1806-4841.2017920601.
6
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.巴西麻风病患者统一多药疗法(U-MDT/CT-BR):多菌型患者开放标签、随机对照临床试验结果
PLoS Negl Trop Dis. 2017 Jul 13;11(7):e0005725. doi: 10.1371/journal.pntd.0005725. eCollection 2017 Jul.
7
Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.全基因组测序可区分复发性麻风病例中的复发和再感染情况。
PLoS Negl Trop Dis. 2017 Jun 15;11(6):e0005598. doi: 10.1371/journal.pntd.0005598. eCollection 2017 Jun.
8
International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.麻风病患者统一多药治疗方案的国际开放试验:研究结果及对国家麻风病防治规划的启示
Indian J Med Res. 2016 Oct;144(4):525-535. doi: 10.4103/0971-5916.200888.
9
Uniform multidrug therapy for leprosy - time for a rethink?麻风病的统一多药疗法——是时候重新思考了吗?
Indian J Med Res. 2016 Oct;144(4):499-501. doi: 10.4103/0971-5916.200884.
10
Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).麻风反应:在巴西麻风病患者队列(U-MDT/CT-BR)中评估的麻风分枝杆菌特异性血清学的预测价值
PLoS Negl Trop Dis. 2017 Feb 21;11(2):e0005396. doi: 10.1371/journal.pntd.0005396. eCollection 2017 Feb.